SusanRRheingoldMD

PubMed

• Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
  Nicole Wolfset, Amir Reza Pashmineh Azar, Charles A Phillips, Madison Stein, Susan R Rheingold, Jennifer Heimall, Caitlin W Elgarten> ;Journal of Pediatric Hematology/oncology. 2024 Mar 1
• 1 citations
  INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
  Lena E Winestone, Deepa Bhojwani, Sara Ghorashian, Lori Muffly, Allison Barz Leahy, Karen Chao, Angela Steineck, Claudia Rössig, Adam Lamble, Shannon L Maude, Regina M...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia.
  Joshua Anil, Ahab Alnemri, Andrew Lytle, Brian Lockhart, Ashley E Anil, Michael Baumgartner, Kirubel Gebre, Jared McFerran, Stephan A Grupp, Susan R Rheingold, Vinodh ...> ;American Journal of Hematology. 2023 Dec 1
• 5 citations
  Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
  Haley Newman, Yimei Li, Hongyan Liu, Regina M Myers, Vicky Tam, Amanda DiNofia, Lisa Wray, Susan R Rheingold, Colleen Callahan, Claire White, Diane Baniewicz, Lena E W...> ;Blood. 2023 Feb 9
• 7 citations
  Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.
  Valeria Ceolin, Erica Brivio, Harm van Tinteren, Susan R Rheingold, Allison Leahy, Britta Vormoor, Maureen M O'Brien, Jeremy D Rubinstein, Krzysztof Kalwak, Barbara De...> ;Leukemia. 2023 Jan 1
• 2 citations
  Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's On...
  Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, Zhiguo Chen, Susan Conway, Meenakshi Devidas, Sumit Gupta, John A Kairalla, Jennifer L McNeer, Maureen M O'Brien,...> ;Pediatric Blood & Cancer. 2022 Nov 1
• 6 citations
  Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
  Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W Le...> ;Blood Advances. 2022 Sep 13
• 47 citations
  Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
  Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
• 33 citations
  Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
  Allison Barz Leahy, Kaitlin J Devine, Yimei Li, Hongyan Liu, Regina Myers, Amanda DiNofia, Lisa Wray, Susan R Rheingold, Colleen Callahan, Diane Baniewicz, Maria Patin...> ;Blood. 2022 Apr 7
• 2 citations
  Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
  Nicole J Wayne, Yimei Li, Perry Chung, Kristin Coffan, Susan R Rheingold> ;Pediatric Blood & Cancer. 2022 Apr 1
• 33 citations
  Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol...
  Maureen M O'Brien, Lingyun Ji, Nirali N Shah, Susan R Rheingold, Deepa Bhojwani, Constance M Yuan, Xinxin Xu, Joanna S Yi, Andrew C Harris, Patrick A Brown, Michael J ...> ;Journal of Clinical Oncology. 2022 Mar 20
• 8 citations
  Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Child...
  Sarah K Tasian, Lewis B Silverman, James A Whitlock, Richard Sposto, Joseph P Loftus, Eric S Schafer, Kirk R Schultz, Raymond J Hutchinson, Paul S Gaynon, Etan Orgel, ...> ;Haematologica. 2022 Oct 1
• 84 citations
  Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
  Regina M. Myers, Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates, Alexandra E. Kovach, Brent L. Wood, Michael J. Borowitz, Marya...> ;Journal of Clinical Oncology. 2021 Nov 12
• 46 citations
  CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinica...
  Allison Barz Leahy, Haley Newman, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda M. DiNofia, Joseph G Dolan, Colleen Callahan, Diane Baniewicz, Kaitlin Devine, Lisa Wr...> ;The Lancet. Haematology. 2021 Oct 1
• 3 citations
  Hematopathologic Correlates of CAR T-Cell Therapy.
  J. Gregory Dolan, Michele Paessler, Susan R. Rheingold, Vinodh Pillai> ;Clinics in Laboratory Medicine. 2021 Jul 1
• 71 citations
  Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic ...
  Regina M. Myers, Yimei Li, Allison Barz Leahy, David M. Barrett, David T. Teachey, Colleen Callahan, Christina Fasano, Susan R. Rheingold, Amanda M. DiNofia, Lisa Wray...> ;Journal of Clinical Oncology. 2021 Jun 22
• 15 citations
  Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
  Antonio Arrieta, Michael Neely, J. Christopher Day, Susan R. Rheingold, Paul K. Sue, William J Muller, Lara Danziger-Isakov, Julie Chu, Inci Yildirim, Grace A. McComse...> ;Antimicrobial Agents and Chemotherapy. 2021 May 24
• 4 citations
  An owner's manual for CD19 "CAR"-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia.
  Theodore W. Laetsch, Gregory A. Yanik, Michael Boyer, Susan R. Rheingold> ;Blood Reviews. 2021 May 6
• 21 citations
  Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse
  Sophia Faude, Jane Wei, Kavitha Muralidharan, Xiaoming Xu, Gerald Wertheim, Michele Paessler, Vijay Bhoj, Stephan A. Grupp, Shannon L. Maude, Susan R. Rheingold, Vinod...> ;Blood Advances. 2021 Apr 27
• 24 citations
  Modulation of CD22 protein expression in childhood leukemia by pervasive splicing aberrations: implications for CD22-directed immunotherapies
  Sisi Zheng, Elisabeth Gillespie, Ammar S. Naqvi, Katharina E. Hayer, Zhiwei Ang, Manuel Torres-Diz, Mathieu Quesnel-Vallieres, David A Hottman, Asen Bagashev, John Chu...> ;Blood Cancer Discovery. 2021 Jan 1
• 2 citations
  How we infuse blinatumomab.
  Katelyn Oranges, Sarah Windawi, Stephanie Powell, David Dallago, Nicole Escobar, Susan R. Rheingold> ;Pediatric Blood & Cancer. 2020 Sep 1
• 55 citations
  Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic.
  Yang-Yang Ding, Sneha Ramakrishna, Adrienne H. Long, Charles A. Phillips, Raul Montiel-Esparza, Caroline Diorio, L. Charles Bailey, Shannon L. Maude, Richard Aplenc, V...> ;Pediatric Blood & Cancer. 2020 Sep 1
• 3 citations
  Summary of COVID-19 clinical practice adjustments across select institutions.
  Liora M. Schultz, Michael P. Link, Susan R. Rheingold, Douglas S. Hawkins, Jeffrey S. Dome, Jonathan E. Wickiser, Andrew L. Kung, Tara O. Henderson, Catherine Aftandilian> ;Pediatric Blood & Cancer. 2020 Jul 19
• 21 citations
  Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group ...
  Glen Lew, Yichen Chen, Xiaomin Lu, Susan R. Rheingold, James A. Whitlock, Meenakshi Devidas, Caroline Hastings, Naomi J. Winick, William L. Carroll, Brent L. Wood, Mic...> ;Haematologica. 2020 Jan 30
• 13 citations
  Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
  Nirali N. Shah, Deepa Bhojwani, Keith J. August, André Baruchel, Yves Bertrand, Jessica Boklan, Luciano Dalla-Pozza, Robyn M. Dennis, Nobuko Hijiya, Franco Locatelli, ...> ;Pediatric Blood & Cancer. 2020 May 1
• Join now to see all

Journal Articles

• Inotuzumab Ozogamicin in Pediatric Patients with relapsed/refractory Acute Lymphoblastic Leukemia  
  Deepa Bhojwani, Constance Yuan, Jennifer L McNeer, Mignon L Loh, Vilmarie Rodriguez, Susan R Rheingold, Elizabeth A Raetz, Nature
• Non-Viral RNA Chimeric Antigen Receptor Modified T Cells in Patients with Hodgkin Lymphoma  
  Stephan A Grupp, Sunita Dwivedy Nasta, Susan R Rheingold, Daniel J Landsburg, Carl H June, Jakub Svoboda, Stephen J Schuster, Saar I Gill, David L Porter, Bruce L Levine, Blood

Abstracts/Posters

• Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy
  Susan R. Rheingold, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
  Susan R. Rheingold, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children’s Oncology Group (COG) study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clini... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018